{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004232015051648.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.bmc.2010.07.020"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0968089610006632?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0968089610006632?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"20696580"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Selective inhibition of methoxyflavonoids on human CYP1B1 activity"}],"description":[{"notation":[{"@value":"Cytochrome P450 (CYP) 1B1 catalyzes 17beta-estradiol (E(2)) to predominantly carcinogenic 4-hydroxy-E(2), whereas CYP1A1 and 1A2 convert E(2) to non-carcinogenic 2-hydroxy-E(2). Hence, selective inhibition of CYP1B1 is recognized to be beneficial for the prevention of E(2) related breast cancer. In this study, we first evaluated the structure-property relationship of 18 major flavonoids on inhibiting enzymatic activity of CYP1A1, 1A2 and 1B1 by using an ethoxyresorufin O-deethylation assay. Flavones and flavonols indicated relatively strong inhibitory effects on CYP1s compared with flavanone that does not have the double bond between C-positions 2 and 3 on the C-ring. Flavonoids used in this study selectively inhibited CYP1B1 activity. In particular, methoxy types of flavones and flavonols such as chrysoeriol and isorhamnetin showed strong and selective inhibition against CYP1B1. To understand why selective inhibition was observed, we carried out a molecular docking analysis of these methoxyflavonoids with the 2-3 double bond and CYP1s. The results suggested that chrysoeriol and isorhamnetin fit well into the active site of CYP1B1, but do not fit into the active site of CYP1A2 and 1A1 because of steric collisions between the methoxy substituent of these methoxyflavonoids and Ser-122 in CYP1A1 and Thr-124 in CYP1A2. In conclusion, our results demonstrate: (1) strong inhibitory effects of flavonoids on CYP1 activities require the 2-3 double bond on the C-ring; (2) methoxyflavonoids with the 2-3 double bond had strong and selective inhibition against CYP1B1, suggesting chemopreventive flavonoids for E(2) related breast cancer; and (3) binding specificity of these methoxyflavonoids is based on the interactions between the methoxy groups and specific CYP1s residues."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420001326233676288","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60295558"},{"@type":"NRID","@value":"1000060295558"},{"@type":"NRID","@value":"9000019183745"}],"foaf:name":[{"@value":"Hitomi Takemura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232015051649","@type":"Researcher","foaf:name":[{"@value":"Toshimasa Itoh"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232015051652","@type":"Researcher","foaf:name":[{"@value":"Keiko Yamamoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232015051650","@type":"Researcher","foaf:name":[{"@value":"Hiroyuki Sakakibara"}]},{"@id":"https://cir.nii.ac.jp/crid/1420564276170205440","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10162728"},{"@type":"NRID","@value":"1000010162728"},{"@type":"CINII_AUTHOR_ID","@value":"DB00166791"},{"@type":"URI","@value":"https://ci.nii.ac.jp/author/DB00166791#entity"},{"@type":"URI","@value":"https://viaf.org/viaf/NII%7CDB00166791"},{"@type":"NRID","@value":"9000323300179"},{"@type":"NRID","@value":"9000361231306"},{"@type":"NRID","@value":"9000014578202"},{"@type":"NRID","@value":"9000283423080"},{"@type":"NRID","@value":"9000409325457"},{"@type":"NRID","@value":"9000019985293"},{"@type":"NRID","@value":"9000019183746"}],"foaf:name":[{"@value":"Kayoko Shimoi"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09680896"}],"prism:publicationName":[{"@value":"Bioorganic & Medicinal Chemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2010-09","prism:volume":"18","prism:number":"17","prism:startingPage":"6310","prism:endingPage":"6315"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0968089610006632?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0968089610006632?httpAccept=text/plain"}],"createdAt":"2010-07-14","modifiedAt":"2025-10-18","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Flavonoids","dc:title":"Flavonoids"},{"@id":"https://cir.nii.ac.jp/all?q=Models,%20Molecular","dc:title":"Models, Molecular"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P-450%20CYP1A2%20Inhibitors","dc:title":"Cytochrome P-450 CYP1A2 Inhibitors"},{"@id":"https://cir.nii.ac.jp/all?q=Structure-Activity%20Relationship","dc:title":"Structure-Activity Relationship"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P-450%20Enzyme%20System","dc:title":"Cytochrome P-450 Enzyme System"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P-450%20CYP1A2","dc:title":"Cytochrome P-450 CYP1A2"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P-450%20CYP1B1","dc:title":"Cytochrome P-450 CYP1B1"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P-450%20CYP1A1","dc:title":"Cytochrome P-450 CYP1A1"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P-450%20Enzyme%20Inhibitors","dc:title":"Cytochrome P-450 Enzyme Inhibitors"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Aryl%20Hydrocarbon%20Hydroxylases","dc:title":"Aryl Hydrocarbon Hydroxylases"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782132098944","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22700763"},{"@type":"JGN","@value":"JP22700763"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22700763/"}],"notation":[{"@language":"ja","@value":"ホルモン依存性癌発生に関わるDNA損傷に対するメトキシフラボノイドの予防効果"},{"@language":"en","@value":"Inhibitory effects of methoxyflavonoid on DNA damage induced by catechol estrogen"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004233178398208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A 3D Model of CYP1B1 Explains the Dominant 4-Hydroxylation of Estradiol"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145605648384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145793280768","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145847480576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619249566208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Flavonoids and tyrosine nitration: structure–activity relationship correlation with enthalpy of formation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093480354816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093884947072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibition of human cytochrome CYP1 enzymes by flavonoids of St. John's wort"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094354350976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structure−Activity Relationships of Flavonoids in the Cellular Antioxidant Activity Assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095586599168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657253801088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Quercetin-3-O-glucronide inhibits noradrenaline binding to α2-adrenergic receptor, thus suppressing DNA damage induced by treatment with 4-hydroxyestradiol and noradrenaline in MCF-10A cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568697331840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569745318272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Plant-derived phenolic antioxidants"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570629584640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Simultaneous Determination of All Polyphenols in Vegetables, Fruits, and Teas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571372057728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043541779840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045879382272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antioxidant and Prooxidant Behavior of Flavonoids: Structure-Activity Relationships"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519238348416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Catecholestrogens are MCF-7 cell estrogen receptor agonists"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521488167680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995636151040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"4-Hydroxylation of estrogens as marker of human mammary tumors."}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469092541696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Dietary Flavonoids as Antioxidants"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470162175616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular Characteristics of Catechol Estrogen Quinones in Reactions with Deoxyribonucleosides"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943543054592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944806456576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Flavonoids as Antioxidants"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945622266112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibition of Catechol O-Methyltransferase-catalyzed O-Methylation of 2- and 4-Hydroxyestradiol by Quercetin"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419476521856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolism of exogenous 4- and 2-hydroxyestradiol in the human male"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893517781376","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368847511552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antioxidant and Chemosensitizing Effects of Flavonoids with Hydroxy and/or Methoxy Groups and Structure-Activity Relationship"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370809241088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: Identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794738269568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SAR and QSAR of the Antioxidant Activity of Flavonoids"}]},{"@id":"https://cir.nii.ac.jp/crid/1881428067515674880","@type":"Dataset","relationType":["isReferencedBy","isSourceOf"],"jpcoar:relatedTitle":[{"@value":"BindingDB Entry 50032186: Selective inhibition of methoxyflavonoids on human CYP1B1 activity."}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942007635584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Estrogen- and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.bmc.2010.07.020"},{"@type":"KAKEN","@value":"PRODUCT-13649110"},{"@type":"KAKEN","@value":"PRODUCT-13649117"},{"@type":"OPENAIRE","@value":"doi_dedup___::45602c0d611bbd0b4960067ca071483f"},{"@type":"CROSSREF","@value":"10.1186/s41021-016-0071-7_references_DOI_VPcclT6DNCkvrcNCRXMmsvJtsRw"},{"@type":"CROSSREF","@value":"10.1016/j.jsbmb.2014.02.014_references_DOI_VPcclT6DNCkvrcNCRXMmsvJtsRw"}]}